Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02589223
Other study ID # MSS2015
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date February 16, 2017
Est. completion date September 22, 2017

Study information

Verified date July 2018
Source St. Michael's Hospital, Toronto
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

St. Michael's Hospital (SMH) provides service to individuals with some of the most severe brain injuries and intensive care needs in Canada. These patients often require prolonged intensive care admissions, lengthy hospital stays, involvement of many health professionals, and long-term support for ongoing care requirements. Many hospitals face resource limitations, specifically involving the health disciplines and their ability to provide frequent intervention.

It has been proposed that multisensory stimulation (i.e. exposing the patient to various sights, sounds, smells, etc.) in the early stages of brain injury recovery may result in improved responsiveness/cognitive function.

Previous research has indicated a potential benefit for early multisensory stimulation intervention for patients with severe brain injury. However there is still not enough conclusive evidence to confirm whether the intervention is truly effective. The investigators are proposing a pilot randomized controlled study (placebo-controlled, double-blinded) to determine the feasibility and examine the effectiveness of early multisensory stimulation with patients following severe brain injury who remain in a coma, vegetative state, or minimally conscious state. Eligible patients will be randomized to a control group (standard care + family/caregiver education) or an intervention group (standard care + family/caregiver education + early sensory intervention). Data regarding number of patients enrolled, amount of intervention completed, percentage of outcome data collected, patient's level of responsiveness and cognitive function will be collected before and after the intervention period, using several outcome measures. The investigators hope to determine the feasibility of conducting this type of study within this clinical setting and the effectiveness of multisensory stimulation with this patient population.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date September 22, 2017
Est. primary completion date September 22, 2017
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria:

- At least 2 weeks post injury, no more than 8 weeks post injury

- Glasgow Coma Scale score of less than or equal to 9, or motor component score of 5 or less if patient intubated

- No previous brain injury

- No chronic/progressive neurological illness

- No intracranial pressure monitor

- No more than1 pre-existing sensory impairment (e.g. deafness, blindness)

- Functional level of English for patient and Substitute Decision Maker (i.e. conversational English, work/education in English, completion of English as a Second Language course, etc.)

- Deemed medically appropriate as per Nurse Practitioner/MD (e.g. no active seizures, no sedation, haemodynamically stable, etc.)

Exclusion Criteria: Patients who do not meet inclusion criteria above.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Multisensory Stimulation
Subjects assigned to the multisensory stimulation group will receive the multisensory stimulation protocol designed for the study, which will include a variety of techniques designed to awaken the individual. Stimulus provided may include: visual activities (i.e. presenting the individual with objects/pictures to look at), auditory information (i.e. playing music or speaking), tactile stimuli (i.e. touching the individual with materials of different textures), taste and smell stimuli (i.e. offering items for the individual to taste or smell).
Control
Intervention sessions will occur 3 times per week, for approximately 30 minutes per session for a total of 4 weeks. During each session, subjects will be played a pre-recorded reading of complex material for 30 minutes, in order to assist with control/blinding.

Locations

Country Name City State
Canada St. Michael's Hospital Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
St. Michael's Hospital, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Western Neurosensory Stimulation Profile - to assess change in alertness and cognitive functioning To be administered pre intervention (once consent obtained and prior to intervention - to obtain baseline data) and post intervention (after 4 week intervention period to determine change in alertness/cognitive functioning post intervention).
Secondary Ranchos Los Amigos Levels of Cognitive Functioning Scale To be administered pre intervention (once consent obtained and prior to intervention - to obtain baseline data) and post intervention (after 4 week intervention period to determine change in alertness/cognitive functioning post intervention).
Secondary Glasgow Coma Scale To be administered pre intervention (once consent obtained and prior to intervention - to obtain baseline data) and post intervention (after 4 week intervention period to determine change in alertness/responsiveness post intervention).
Secondary Enrollment rates To be collected during the patient enrollment process (study duration approximately 1 year).
Secondary Barriers to enrollment To be collected during the patient enrollment process (study duration approximately 1 year).
Secondary Duration of each intervention session (minutes) To be collected at the end each intervention session throughout the 4 week intervention period.
Secondary Pre/post-intervention heart rate (beats/minute) To be collected at the beginning and end of each intervention session throughout the 4 week intervention period.
Secondary Sp02 reading (percentage) To be collected at the beginning and end of each intervention session throughout the 4 week intervention period.
Secondary Respiratory Rate (breaths/minute) To be collected at the beginning and end of each intervention session throughout the 4 week intervention period.
Secondary ICU Mobility Scale Score Daily scores are recorded and eventually averaged over 4 week intervention period.
Secondary Number of intervention sessions (control or multisensory stimulation) per patient over 4 week period To be collected at the end of 4 week intervention period.
Secondary Barriers to intervention To be collected (as applicable) at the end of each intervention session throughout the 4 week intervention period.
Secondary Date of patient transfer from TNICU to ward To be collected when patient transferred from TNICU to ward (which may be at any time throughout study period, up to 6 months after study enrollment).
Secondary Patient length of stay (days) To be collected when patient is discharged/transferred from hospital. (which will be at any time, up to 6 months after study enrollment).
Secondary Discharge Destination To be recorded when patient is discharged/transferred from hospital (which will be at any time, up to 6 months after study enrollment).
See also
  Status Clinical Trial Phase
Completed NCT03998930 - Evaluation of Consciousness by Brain-computer Interface in Severely Brain Damaged Patients N/A
Recruiting NCT05636020 - Intervention to Change Affect Recognition and Empathy N/A
Completed NCT04306601 - Low-Intensity Focused Ultrasound on Individuals With Disorder of Consciousness of Traumatic Brain Injury N/A